MedPath
NMPA Approval

Vonoprazan Fumarate Tablets

国药准字HJ20190064

September 24, 2024

H20190064

Drug Information

富马酸伏诺拉生片

沃克

片剂

按C₁₇H₁₆FN₃O₂S计 10mg

化学药品

September 24, 2024

September 23, 2029

Company Information

Applicant Company

1-1,Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan

Manufacturing Company

takeda pharmaceutical company limited, hikari plant

4720,Takeda, Mitsui,Hikari,Yamaguchi 743-8502, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸伏诺拉生片 - NMPA 批准文号 | MedPath